PATENT CLAIM ANALYSIS

Application Number: 16003994
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "183000"]

Abstract:
Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.

Claim (Index 10):
The method of  claim 1 , wherein the subject has blood pressure values greater than or equal to 140/90 mmm Hg.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 94.0
- Lexical Diversity: 1.27586
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15802341', '15613622', '15081603', '15483691', '15268095']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7979477813860579
- 35 USC 102 Novelty (BERT): 0.598853534270053
- Combined Prediction Score: 0.7780383566744574
- Mean Citation Score: 413.644672
- Max Citation Score: 461.79395
- Similarity Product: 453.2673181411057

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test